Establishment Labs Holdings (ESTA) Cash & Equivalents (2022 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Cash & Equivalents came in at $68.1 million in Q1 2026, up 4156.31% year-on-year from $1.6 million in Q1 2025, and up 7466.78% quarter-over-quarter from $900000.0 in Q3 2025.
Establishment Labs Holdings (ESTA) Cash & Equivalents (2022 - 2026) Analysis & Trends
Establishment Labs Holdings' Cash & Equivalents history runs 5 years deep, the most recent figure standing at $68.1 million for Q1 2026.
- On a quarterly basis, Cash & Equivalents rose 4156.31% year-over-year to $68.1 million in Q1 2026; TTM through Mar 2026 was $68.1 million, a 4156.31% increase from a year earlier, with the FY2024 full-year figure at $3.0 million, down 92.51% from the prior year.
- Cash & Equivalents advanced to $68.1 million in Q1 2026 per ESTA's latest filing, from $900000.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $68.1 million in Q1 2026 and bottomed at $900000.0 in Q3 2025.
- The 5-year median for Cash & Equivalents is $40.0 million (2023), against an average of $33.5 million.
- Across the five-year window, Cash & Equivalents tumbled 92.51% in 2024 and soared 4156.31% in 2026, its largest moves.
- Year by year, Cash & Equivalents stood at $66.4 million in 2022, then tumbled by 39.67% to $40.0 million in 2023, then tumbled by 92.51% to $3.0 million in 2024, then sank by 70.0% to $900000.0 in 2025, then jumped by 7466.78% to $68.1 million in 2026.
- Per Business Quant, the three latest ESTA Cash & Equivalents figures stand at $68.1 million (Q1 2026), $900000.0 (Q3 2025), and $54.6 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | 68.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.10 Mn |
| Sep 30, 2025 | 900,000.00 |
| Jun 30, 2025 | 54.64 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 40.04 Mn |
| Dec 31, 2022 | 66.36 Mn |